KMT2A and precursor B-cell acute lymphoblastic leukemia: Among 161 evaluated KMT2A-wildtype Interfant-enrolled infants with B-ALL, 35 (21.7%) were NUTM1-rearranged (Supplementary Fig. S1 and Supplementary Table S2).